Overlap of Diseases Underlying Ischemic Stroke
Gaia Sirimarco(Inserm), Pierre Amarenco(Assistance Publique – Hôpitaux de Paris), Julien Labreuche(ASTER), Elena Meseguer(Université Paris Cité), Philippa C. Lavallée(Université Claude Bernard Lyon 1), Valérie Adraï(MACOM (United States)), Mikaël Mazighi(Inserm), Pierre‐Jean Touboul(Délégation Paris 7), Halim Abboud(Saint Joseph University), Jean‐Marc Olivot(Stanford University), Samina Ratani(MACOM (United States)), Jérôme Kusmierek(MACOM (United States)), Lucie Cabrejo(Délégation Paris 7), Céline Guidoux(Inserm), Isabelle Klein(Délégation Paris 7), Philippe Gabríel Steg(Mount Sinai Hospital)
Cited by 49
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k